Breast cancer develops when cells in the breast accumulate genetic damage that allows them to grow uncontrollably. No single cause explains every case. Instead, a combination of factors, including inherited genetics, hormone exposure, body composition, lifestyle, and reproductive history, work together to raise or lower risk over a lifetime. About 13% of women will develop breast cancer at some point, with a median age of diagnosis around 64.
Inherited Gene Mutations
The most well-known genetic risk factors are mutations in the BRCA1 and BRCA2 genes. These genes normally help repair damaged DNA in breast cells. When they carry harmful changes, that repair system fails, and errors accumulate. More than 60% of women who inherit a harmful BRCA1 or BRCA2 mutation will develop breast cancer during their lifetime, roughly four to five times the rate in the general population.
BRCA mutations get the most attention, but they account for a relatively small share of all breast cancers. Most cases are “sporadic,” meaning they arise from genetic damage that accumulates over a person’s life rather than being passed down from a parent. In sporadic breast cancers, the most frequently mutated genes include TP53 (found in about 36% of tumors) and PIK3CA (about 28%). Several other genes, including GATA3 and ERBB2, also show up repeatedly. You don’t need to know those names, but the takeaway matters: even without an inherited mutation, the DNA inside breast cells can acquire errors through normal aging, hormone exposure, or environmental factors.
How Hormones Drive Cell Growth
Estrogen and progesterone are the central hormonal players. Both hormones signal breast cells to divide, and every round of cell division creates an opportunity for a copying error in the cell’s DNA. The more total exposure your breast tissue has to these hormones over your lifetime, the more chances there are for something to go wrong. Estrogen and progesterone promote breast cell proliferation by activating proteins that push cells through their growth cycle faster than normal.
This is why several seemingly unrelated risk factors all point back to the same mechanism. Starting your period early (before 12), reaching menopause late (after 55), or never having children all extend the total number of menstrual cycles you experience, and therefore the total window of hormone-driven cell division in the breast.
Reproductive History and Breastfeeding
Pregnancy and breastfeeding both reduce breast cancer risk, and the effects stack. Each birth lowers the relative risk by about 7%, and every 12 months of breastfeeding reduces it by an additional 4.3%. That protective effect holds regardless of income level, ethnic group, or menopausal status.
Timing matters, too. Women who had their first full-term pregnancy before age 25 get a lasting protective benefit. In contrast, women who had three or more children but didn’t deliver their first until after 25, and who did not breastfeed, showed a dramatically higher risk. The biology behind this likely involves the way pregnancy permanently changes breast cell structure, making those cells more resistant to future genetic damage.
Body Weight and Estrogen After Menopause
After menopause, the ovaries largely stop producing estrogen. But fat tissue picks up the slack. Adipose (fat) cells contain an enzyme called aromatase that converts other hormones into estrogen. The more fat tissue you carry, the more estrogen your body produces through this pathway. The conversion rate increases with both age and the volume of fat tissue, which is why postmenopausal obesity is a well-established breast cancer risk factor.
This creates a particular problem after menopause. Estrogen levels in visceral fat tissue (the fat around your organs) are actually higher than levels circulating in the blood. So even though overall estrogen drops after menopause, localized estrogen in fatty tissue can remain high enough to stimulate breast cell growth. The shift in fat distribution that often accompanies menopause, from hips and thighs toward the abdomen, adds to this effect.
Alcohol Consumption
Alcohol is one of the most clearly dose-dependent lifestyle risk factors. A large meta-analysis of prospective studies found that breast cancer risk increases by about 10.5% for every 10 grams of alcohol consumed per day. That’s roughly one standard drink. Two drinks a day means roughly a 21% increase. For postmenopausal women, the increase is slightly steeper at 11.1% per 10 grams.
The effect is strongest for estrogen-receptor-positive breast cancers, which fits the hormonal theory: alcohol raises circulating estrogen levels and may also impair the body’s ability to break estrogen down. Wine showed similar risk increases to other types of alcohol, so switching from liquor to wine doesn’t offer protection.
Breast Density
Women with extremely dense breast tissue have about 2.4 times the breast cancer risk compared to women with mostly fatty breasts. Even moderately dense breasts carry roughly double the risk. Dense tissue contains more connective and glandular tissue relative to fat, which means more cells that can potentially become cancerous and a harder time spotting tumors on a mammogram.
Breast density is largely determined by genetics, age, and hormonal status. It tends to decrease after menopause. Many states now require that mammography reports include information about your breast density so you can discuss additional screening options if needed.
Hormone Replacement Therapy
Not all hormone therapy carries the same risk. Combined estrogen-progestogen therapy (the type commonly used to treat hot flashes and other menopause symptoms) is associated with about a 10% higher rate of breast cancer compared to never using hormone therapy. That rate climbs to 18% for women who use it for more than two years. In practical terms, the cumulative risk of breast cancer before age 55 rises from about 4.1% (no therapy) to roughly 4.5% with combined therapy.
Estrogen-only therapy, typically prescribed to women who have had a hysterectomy, tells a different story. It was associated with a 14% reduction in breast cancer incidence. The difference reinforces the role of progestogen specifically in promoting breast cell growth.
Radiation Exposure
Ionizing radiation damages DNA directly. Women who received radiation therapy to the chest area during childhood or young adulthood, often for Hodgkin lymphoma, have a significantly elevated lifetime risk. The younger the exposure, the greater the risk, because breast tissue is still developing and more vulnerable to genetic damage.
Routine mammograms do involve a small dose of radiation, but it’s extremely low. The screening benefit of catching cancer early far outweighs the tiny theoretical risk from the X-rays themselves. The concern is primarily with repeated or high-dose medical radiation to the chest, especially before age 30.
Age Is the Biggest Single Factor
More than two-thirds of breast cancers are diagnosed in women over 55. The age group with the highest share of new diagnoses is 65 to 74, accounting for about 27.5% of all cases. Only about 2% of cases occur in women under 35. This pattern reflects the cumulative nature of breast cancer: it takes years or decades for enough genetic damage to accumulate in a single cell line to trigger uncontrolled growth. Every year of aging adds more exposure to hormones, environmental insults, and random DNA replication errors.
That said, younger women do get breast cancer, and their tumors tend to be more aggressive. Age under 50 doesn’t rule it out, which is why knowing your other risk factors matters regardless of how old you are.